6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: June 30, 2020
Period of Report: June 30, 2020
Accession Number: 0001213900-20-016231

View Document ↗ View on SEC.gov ↗